Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of the health quality of Ria de Aveiro (Portugal): heavy metals and benthic foraminifera.
Martins VA, Frontalini F, Tramonte KM, Figueira RC, Miranda P, Sequeira C, Fernández-Fernández S, Dias JA, Yamashita C, Renó R, Laut LL, Silva FS, Rodrigues MA, Bernardes C, Nagai R, Sousa SH, Mahiques M, Rubio B, Bernabeu A, Rey D, Rocha F. Martins VA, et al. Mar Pollut Bull. 2013 May 15;70(1-2):18-33. doi: 10.1016/j.marpolbul.2013.02.003. Epub 2013 Apr 10. Mar Pollut Bull. 2013. PMID: 23582314
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Pereira RMR, Dagostin MA, Caparbo VF, Sales LP, Pasoto SG, Silva CA, Yuki EFN, Saad CGS, Medeiros-Ribeiro AC, Kupa LVK, Fusco SRG, Martins VAO, Martins CCMF, Barbas CV, Shinjo SK, Aikawa NE, Bonfa E. Pereira RMR, et al. Among authors: martins vao. Clinics (Sao Paulo). 2022 Nov 29;78:100150. doi: 10.1016/j.clinsp.2022.100150. eCollection 2023. Clinics (Sao Paulo). 2022. PMID: 36529052 Free PMC article.
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Silva CA, Medeiros-Ribeiro AC, Kupa LVK, Yuki EFN, Pasoto SG, Saad CGS, Fusco SRG, Pereira RMR, Shinjo SK, Halpern ASR, Borba EF, Souza FHC, Guedes LKN, Miossi R, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Andrade DCO, Seguro LPC, Fuller R, Sampaio-Barros PD, Assad APL, Moraes JCB, Goldenstein-Schainberg C, Giardini HAM, Silva HC, Martins VAO, Villamarin LEB, Novellino RS, Sales LP, Araújo CSR, Silva MSR, Filho DMN, Lopes MH, Duarte AJS, Kallas EG, Aikawa NE, Bonfa E. Silva CA, et al. Among authors: martins vao. Nat Commun. 2022 Oct 3;13(1):5801. doi: 10.1038/s41467-022-33042-0. Nat Commun. 2022. PMID: 36192386 Free PMC article.
Profile of tobacco growers with green tobacco sickness in Southern Brazil.
Pappen M, Martins VA, Renner JDP, Reuter CP, Krug SBF. Pappen M, et al. Among authors: martins va. Rev Bras Med Trab. 2022 Jun 30;20(2):311-316. doi: 10.47626/1679-4435-2022-686. eCollection 2022 Apr-Jun. Rev Bras Med Trab. 2022. PMID: 36127912 Free PMC article.
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Aikawa NE, Kupa LVK, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Rojo PT, Pereira RMR, Shinjo SK, Sampaio-Barros PD, Andrade DCO, Halpern ASR, Fuller R, Souza FHC, Guedes LKN, Assad APL, Moraes JCB, Lopes MRU, Martins VAO, Betancourt L, Ribeiro CT, Sales LP, Bertoglio IM, Bonoldi VLN, Mello RLP, Balbi GGM, Sartori AMC, Antonangelo L, Silva CA, Bonfa E. Aikawa NE, et al. Among authors: martins vao. Ann Rheum Dis. 2022 Jul;81(7):1036-1043. doi: 10.1136/annrheumdis-2021-222096. Epub 2022 Mar 11. Ann Rheum Dis. 2022. PMID: 35277389
Influenza A/Singapore (H3N2) component vaccine in systemic lupus erythematosus: A distinct pattern of immunogenicity.
Claudino Formiga FF, Silva CA, Pedrosa TDN, Aikawa NE, Pasoto SG, Garcia CC, Capão ASV, Martins VAO, Proença ACT, Fuller R, Yuki EFN, Vendramini MBG, Rosário DCD, Brandão LMKR, Sartori AMC, Antonangelo L, Bonfá E, Borba EF. Claudino Formiga FF, et al. Among authors: martins vao. Lupus. 2021 Oct;30(12):1915-1922. doi: 10.1177/09612033211040371. Epub 2021 Aug 28. Lupus. 2021. PMID: 34459317
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, Rojo PT, Pereira RMR, Shinjo SK, Andrade DCO, Sampaio-Barros PD, Ribeiro CT, Deveza GBH, Martins VAO, Silva CA, Lopes MH, Duarte AJS, Antonangelo L, Sabino EC, Kallas EG, Pasoto SG, Bonfa E. Medeiros-Ribeiro AC, et al. Among authors: martins vao. Nat Med. 2021 Oct;27(10):1744-1751. doi: 10.1038/s41591-021-01469-5. Epub 2021 Jul 30. Nat Med. 2021. PMID: 34331051 Clinical Trial.
23 results